IV: have epinephrine readily available ... Concomitant mTOR inhibitors (eg, sirolimus, everolimus) may increase risk of thrombotic microangiopathy. Concomitant strong CYP3A4 inhibitors/inducers ...

Continued use of systemic glucocorticoids, a calcineurin inhibitor (tacrolimus or cyclosporine), or a mammalian target of rapamycin (mTOR) inhibitor (sirolimus or everolimus) that the patient was ...

IV: have epinephrine readily available ... Concomitant mTOR inhibitors (eg, sirolimus, everolimus) may increase risk of thrombotic microangiopathy. Concomitant strong CYP3A4 inhibitors/inducers ...

T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited to the pancreas and size 2–4 cm T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor ...

Coronary heart disease (CHD) is a leading cause of morbidity and mortality globally. Hypercholesterolemia is one of the major risk factors for CHD. With the increase in aging populations and ...

During a Case-Based Roundtable® event, Virginia F. Borges, MD, MMSc, discussed treatment selection for a patient with ER+, ...

Due to these and other advances, the overall five-year survival rate for breast cancer is 96%, meaning that 96 out of every ...

Main Camera Triple 12 MP, f/1.7, 24mm (wide), 1/1.7", 1.8µm, dual pixel PDAF, OIS 12 MP, f/2.4, 60mm (telephoto), 1/3.5", dual pixel PDAF, OIS 12 MP, f/2.2, 124 ...

This, of course, is what we’re here to find out as the Enyaq iV 80 arrives on our test fleet. Are its family car credentials about to be rubber stamped or will it be ushered into an adjoining ...

We are working with Guy’s and St. Thomas’ NHS Foundation Trust to produce national standardised SACT regimen-specific consent forms. We want to support clinicians in ensuring all patients are fully ...

as first-line treatment for stage IV or recurrent NSCLC (LBA53) BMS is initiating the Phase 3 RELATIVITY-1093 trial evaluating the fixed-dose combination of nivolumab and relatlimab (FDC 1:1 ...

In fact, the technical make-up of the iV is very similar to the vRS’s. There’s a 1.4-litre turbo petrol engine and a small electric motor, but in this case they produce a total of 201bhp and ...